QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NYSE:BOC

Boston Omaha (BOC) Stock Price, News & Analysis

$16.04
+0.56 (+3.62%)
(As of 04:10 PM ET)
Today's Range
$15.41
$16.08
50-Day Range
$14.87
$16.67
52-Week Range
$13.55
$21.58
Volume
129,288 shs
Average Volume
139,276 shs
Market Capitalization
$502.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.50

Boston Omaha MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
71.4% Upside
$27.50 Price Target
Short Interest
Healthy
3.15% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.66mentions of Boston Omaha in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.88 out of 5 stars

Finance Sector

534th out of 848 stocks

Real Estate Operators (Except Developers) & Lessors Industry

3rd out of 3 stocks

BOC stock logo

About Boston Omaha Stock (NYSE:BOC)

Boston Omaha Corporation, together with its subsidiaries, engages in the outdoor billboard advertising business in the southeast United States. It is also involved in the surety insurance and related brokerage, broadband, and asset management businesses. The company was formerly known as REO Plus, Inc. and changed its name to Boston Omaha Corporation in March 2015. Boston Omaha Corporation was incorporated in 2009 and is headquartered in Omaha, Nebraska.

BOC Stock Price History

BOC Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Boston Omaha Poised for Growth; Maintains Buy Rating with $23 Target
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Negative Corporate News Undercuts Stocks
Boston Omaha: The Cash Is Starting To Roll In
River Oaks Capital H2 2023 Letter
Boston Omaha Financials Flag Warning Signs
Boston Omaha Corp Class A
See More Headlines
Receive BOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Omaha and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/27/2024
Today
4/19/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real estate operators (except developers) & lessors
Sub-Industry
N/A
Fax
N/A
Employees
420
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$27.50
High Stock Price Target
$30.00
Low Stock Price Target
$25.00
Potential Upside/Downside
+76.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-7,000,000.00
Pretax Margin
-9.50%

Debt

Sales & Book Value

Annual Sales
$96.25 million
Cash Flow
$0.59 per share
Book Value
$19.19 per share

Miscellaneous

Free Float
23,127,000
Market Cap
$489.37 million
Optionable
Optionable
Beta
0.77
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Alexander Buffett Rozek (Age 45)
    Co-Chairperson, Co-President & Co-CEO
    Comp: $612.2k
  • Mr. Adam Kenneth Peterson (Age 43)
    Co-Chairperson, Co-President & Co-CEO
    Comp: $612.2k
  • Mr. Joshua Paul Weisenburger (Age 41)
    CFO, Secretary & Treasurer
    Comp: $716.39k
  • Mr. J. Max Meisinger (Age 36)
    Chief Accounting Officer & CFO of Boston Omaha Broadband
  • Mr. Frank DeJoy
    COO of Boston Omaha Broadband
  • Ms. Sydney C. Atkins (Age 41)
    Managing Director
  • Mr. William Scott LaFoy (Age 62)
    Chief Executive Officer of Link Media Holdings, LLC
  • Mr. David Herman (Age 39)
    President of General Indemnity Group LLC
  • Mr. Steven McGhie (Age 57)
    Chief Executive Officer of Fiber Is Fast, Inc.
  • Mr. Robert Frederick Thomas (Age 60)
    President of United Casualty and Surety Insurance Company

BOC Stock Analysis - Frequently Asked Questions

Should I buy or sell Boston Omaha stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Boston Omaha in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BOC shares.
View BOC analyst ratings
or view top-rated stocks.

What is Boston Omaha's stock price target for 2024?

2 Wall Street research analysts have issued twelve-month price objectives for Boston Omaha's shares. Their BOC share price targets range from $25.00 to $30.00. On average, they expect the company's stock price to reach $27.50 in the next year. This suggests a possible upside of 71.4% from the stock's current price.
View analysts price targets for BOC
or view top-rated stocks among Wall Street analysts.

How have BOC shares performed in 2024?

Boston Omaha's stock was trading at $15.73 at the start of the year. Since then, BOC stock has increased by 2.0% and is now trading at $16.04.
View the best growth stocks for 2024 here
.

When is Boston Omaha's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our BOC earnings forecast
.

How were Boston Omaha's earnings last quarter?

Boston Omaha Co. (NYSE:BOC) announced its quarterly earnings results on Wednesday, March, 27th. The company reported ($0.12) earnings per share for the quarter. The company had revenue of $24.67 million for the quarter, compared to the consensus estimate of $25 million. Boston Omaha had a negative trailing twelve-month return on equity of 1.20% and a negative net margin of 7.28%.

Who are Boston Omaha's major shareholders?

Boston Omaha's stock is owned by a variety of retail and institutional investors. Top institutional investors include Compass Ion Advisors LLC (0.04%). Insiders that own company stock include Adam K Peterson, Alexander Buffett Rozek, Brendan Joseph Keating, Frank H Kenan II, Jeffrey C Royal and Joshua Paul Weisenburger.
View institutional ownership trends
.

How do I buy shares of Boston Omaha?

Shares of BOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:BOC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners